Leaps by Bayer is the impact investment unit of Bayer AG. Leaps invests in paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Leaps by Bayer aims to conquer ten huge challenges facing humanity. Some people call them impossible. We call them “leaps.” Much of what we are aiming to achieve is not yet possible. Setbacks and failures are to be expected in dealing with such ambitious targets.
Our approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity.